Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M407Revenue (TTM) $M6.2Net Margin (%)-479.3Altman Z-Score21.1
Enterprise Value $M293EPS (TTM) $-0.2Operating Margin %-497.3Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.7Pre-tax Margin (%)-479.3Higher ROA y-yN
Price/Book3.310-y EBITDA Growth Rate %--Quick Ratio14.8Cash flow > EarningsY
Price/Sales65.65-y EBITDA Growth Rate %--Current Ratio14.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-18,600.0ROA % (ttm)-21.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-22.4Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M159ROIC % (ttm)-149.1Gross Margin Increase y-yN

Gurus Latest Trades with GERN

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

GERN is held by these investors:



GERN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BEHRS MELISSA KELLYEVP BD and Port&Alliance Mgmt 2015-05-29Sell2,380$3.84-33.33view
Bloom Olivia KyusukEVP, CFO 2015-05-29Sell2,380$3.84-33.33view
Hofstaetter ThomasDirector 2015-03-18Sell70,000$4.1-37.56view
Bloom Olivia KyusukEVP, CFO 2014-05-29Sell3,379$2.121.9view
BEHRS MELISSA KELLYEVP Portfolio & Alliance Mgmt 2014-05-29Sell4,826$2.121.9view
BRADBURY DANIELDirector 2014-05-09Buy142,776$1.7546.29view
BEHRS MELISSA KELLYEVP Portfolio & Alliance Mgmt 2014-04-01Sell12,310$2.1320.19view
Bloom Olivia KyusukEVP, CFO 2014-04-01Sell7,435$2.1320.19view
SCARLETT JOHN APresident and CEO 2013-04-01Buy50,000$1.03148.54view
BEHRS MELISSA KELLYSVP Alliance and Prog Mgmt 2013-01-17Sell28,292$1.6555.15view

Press Releases about GERN :

Quarterly/Annual Reports about GERN:

News about GERN:

Articles On GuruFocus.com
Geron 2017 Annual Meeting of Stockholders to be Held on May 9 Apr 25 2017 
Geron Announces Completion of Second Internal Data Reviews for Imetelstat Trials Being Conducted by Apr 10 2017 
Geron Announces Conference Call on April 10 at 8:00 A.M. Eastern Time Apr 09 2017 
Geron Reports Imetelstat Presentation at American Association for Cancer Research Annual Meeting Apr 05 2017 
Geron Corporation Reports Fourth Quarter and Annual 2016 Financial Results Mar 01 2017 
Weekly CEO Buys Highlight: IBTX, INSM, GERN, INO, EQU Apr 07 2013 
WEEKLY CFO SELLS HIGHLIGHT: HTM, OVTI, VSEA, KSWS,GERN, ATRC Jun 20 2011 
Geron Corp. Reports Operating Results (10-Q) Oct 29 2010 
Geron: Buyer Beware Oct 13 2010 
Geron Corp. (GERN) President and CEO Thomas Okarma sells 18,874 Shares Jun 03 2010 

More From Other Websites
Geron 2017 Annual Meeting of Stockholders to be Held on May 9 Apr 25 2017
Today's Research Reports on Biotech Stocks to Watch: Cytori Therapeutics and Geron Apr 11 2017
Geron’s Imetelstat Reports Positive Interim Data Apr 10 2017
Why Geron Corporation Stock Is Surging Higher Today Apr 10 2017
Geron Announces Completion of Second Internal Data Reviews for Imetelstat Trials Being Conducted by... Apr 10 2017
Geron Announces Conference Call on April 10 at 8:00 A.M. Eastern Time Apr 09 2017
ETFs with exposure to Geron Corp. : April 7, 2017 Apr 07 2017
Geron Corp. breached its 50 day moving average in a Bearish Manner : GERN-US : April 6, 2017 Apr 06 2017
Geron Reports Imetelstat Presentation at American Association for Cancer Research Annual Meeting Apr 05 2017
ETFs with exposure to Geron Corp. : March 27, 2017 Mar 27 2017
Today's Research Reports on Stocks to Watch: Geron and Galena Biopharma Mar 20 2017
Geron Corp. :GERN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017 Mar 17 2017
Geron Corp. :GERN-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017 Mar 15 2017
Geron Corp. breached its 50 day moving average in a Bearish Manner : GERN-US : March 15, 2017 Mar 15 2017
Edited Transcript of GERN earnings conference call or presentation 1-Mar-17 9:30pm GMT Mar 03 2017
Geron Announces Presentation at American Association for Cancer Research Annual Meeting Mar 02 2017
Geron Corporation Reports Fourth Quarter and Annual 2016 Financial Results Mar 01 2017
Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2016 Financial Results Feb 22 2017
4 Stocks Under $4 That Could Double Feb 09 2017
Forget Celldex Therapeutics, Inc.: These 2 Stocks Are Better Buys Feb 01 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)